Neoleukin Therapeutics Stock Forecast - Naive Prediction
| NLTXDelisted Stock | USD 0.69 0.01 1.43% |
The Naive Prediction forecasted value of Neoleukin Therapeutics on the next trading day is expected to be 0.56 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.14. Neoleukin Stock Forecast is based on your current time horizon.
Neoleukin |
Neoleukin Therapeutics Naive Prediction Price Forecast For the 12th of November 2024
Given 90 days horizon, the Naive Prediction forecasted value of Neoleukin Therapeutics on the next trading day is expected to be 0.56 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0009, and the sum of the absolute errors of 1.14.Please note that although there have been many attempts to predict Neoleukin Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Neoleukin Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Neoleukin Therapeutics Stock Forecast Pattern
| Backtest Neoleukin Therapeutics | Neoleukin Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Neoleukin Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Neoleukin Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.1136 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0187 |
| MAPE | Mean absolute percentage error | 0.0237 |
| SAE | Sum of the absolute errors | 1.138 |
Predictive Modules for Neoleukin Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neoleukin Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neoleukin Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neoleukin Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neoleukin Therapeutics stock to make a market-neutral strategy. Peer analysis of Neoleukin Therapeutics could also be used in its relative valuation, which is a method of valuing Neoleukin Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Neoleukin Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Neoleukin Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neoleukin Therapeutics shares will generate the highest return on investment. By undertsting and applying Neoleukin Therapeutics stock market strength indicators, traders can identify Neoleukin Therapeutics entry and exit signals to maximize returns.
Neoleukin Therapeutics Risk Indicators
The analysis of Neoleukin Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Neoleukin Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting neoleukin stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.25 | |||
| Standard Deviation | 3.7 | |||
| Variance | 13.69 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Neoleukin Stock
If you are still planning to invest in Neoleukin Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neoleukin Therapeutics' history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |